Task A 87: Therapeutic Testing in Murine Models of Bacterial Infection

任务 A 87：细菌感染小鼠模型的治疗测试

• 批准号: 10933932
• 负责人: LYNN MIESEL
• 金额: $ 68.41万
• 依托单位: PHARMACOLOGY DISCOVERY SERVICES TAIWAN, LTD.
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-08-31 至 2024-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10933932
• 关键词: Animal Model; Bacterial Infections; Contracts; Development; Gram-Negative Bacteria; Licensure; Standardization; bacterial resistance; efficacy testing; infectious disease model; mouse model; therapeutic development; therapeutic evaluation

This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.

该合同规定了传染病小动物模型的开发和标准化，并可能包括候选产品的功效测试，包括支持许可的 GLP 研究。